Danna Lee Jennings MD
Movement Disorder, Neuroimaging, Dementia & Geriatrics
Vice President of Late Clinical Development, Denali Therapeutics
Join to View Full Profile
161 Oyster Point BlvdSouth San Francisco, CA 94080
Phone+1 203-668-5649
Dr. Jennings is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Danna Jennings, MD, is a neurologist with subspecialties in movement disorders, neuroimaging, and dementia & geriatrics. She completed her internal medicine internship and neurology residency at Boston University Medical Center and earned her medical degree from Oregon Health and Science University School of Medicine in 1992. Dr. Jennings has contributed to the field through several publications, including recent studies on olfactory testing in Parkinson's disease. In 2017, Dr. Jennings took her first position in industry on the Alzheimer’s team at Lilly and subsequently moved to Denali Therapeutics in 2019 to lead the development of potential therapeutics for Parkinson’s disease and ALS.
Education & Training
Boston University Medical CenterResidency, Neurology, 1993 - 1996- Boston University Medical CenterInternship, Internal Medicine, 1992 - 1993
Oregon Health and Science University School of MedicineClass of 1992
Publications & Presentations
PubMed
- 1 citationsPredictive value of abbreviated olfactory tests in prodromal Parkinson disease.Pavan A Vaswani, James F Morley, Danna Jennings, Andrew Siderowf, Kenneth Marek
NPJ Parkinson's Disease. 2023-06-29 - 36 citationsLRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson's Disease.Danna Jennings, Sarah Huntwork-Rodriguez, Maurits F J M Vissers, Vinay M Daryani, Dolores Diaz
Movement Disorders. 2023-03-01 - 8 citationsSerial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS study.Pavan A Vaswani, James F Morley, Danna Jennings, Andrew Siderowf, Kenneth Marek
Parkinsonism & Related Disorders. 2022-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
